Dipeptidyl peptidase-3 to predict respiratory outcomes in patients hospitalized with COVID-19: A secondary analysis of a multicenter randomized trial.

Saved in:
Bibliographic Details
Title: Dipeptidyl peptidase-3 to predict respiratory outcomes in patients hospitalized with COVID-19: A secondary analysis of a multicenter randomized trial.
Authors: Teixeira JP; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA; Division of Nephrology, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA. Electronic address: jteixeira@salud.unm.edu., Schaich CL; Hypertension and Vascular Research Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Ten Lohuis CC; Emory Critical Care Center, Emory Healthcare, Atlanta, GA, USA., Nielsen ND; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA; Section of Transfusion Medicine and Therapeutic Pathology, Department of Pathology, University of New Mexico School of Medicine, Albuquerque, NM, USA., Chen P; Women's Guild Lung Institute, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Ginde AA; Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, USA., Hager DN; Department of Medicine, Johns Hopkins University, Baltimore, MD, USA., Khan A; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Oregon Health and Science University, Portland, OR, USA., Merck LH; Department of Emergency Medicine, Virginia Commonwealth University, Richmond, VA, USA., Safdar B; Department of Emergency Medicine, Yale School of Medicine, New Haven, CT, USA., Sturek JM; Division of Pulmonary and Critical Care, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA, USA., de Wit M; Department of Medicine, Virginia Commonwealth University, Richmond, VA, USA., Harkins MS; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA., Self WH; Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt Institute of Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA., Collins SP; Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt Institute of Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA., Busse LW; Emory Critical Care Center, Emory Healthcare, Atlanta, GA, USA; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University, Atlanta, GA, USA.
Corporate Authors: ACTIV-4 Host Tissue Investigators
Source: Journal of critical care [J Crit Care] 2026 Jun; Vol. 93, pp. 155478. Date of Electronic Publication: 2026 Feb 06.
Publication Type: Letter
Journal Info: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 8610642 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8615 (Electronic) Linking ISSN: 08839441 NLM ISO Abbreviation: J Crit Care Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1557-8615
DOI:10.1016/j.jcrc.2026.155478